Roxanne Bales has headed Regulatory and Compliance at NeuroPhage since April 2008. Ms. Bales has over 30 years’ experience in the health science industry, including pharmaceutical and biotechnology development. She worked in Regulatory Affairs at Genentech for 10 years and since 2000 has been working with small biotech/pharma companies in the San Francisco Bay Area and elsewhere to develop innovative therapeutic products. Most recently she led the Regulatory and Compliance group at Rinat Neuroscience Corporation, a biotechnology firm specializing in developing novel approaches to neuroscience-based protein therapeutics, which was purchased by Pfizer in 2006. Roxanne has submitted investigational and marketing applications for proteins made with recombinant DNA technology, especially monoclonal antibodies, as well as small molecule products and devices. Ms. Bales earned her undergraduate and graduate degrees in Chemistry at the University of California Irvine.